SCHEMBL3516150

SCHEMBL3516150

O=C(O)CCC(S)CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3018158 0.85 ENPEP (0.59)
SCHEMBL19182605 0.83 FOLH1 (0.59)
SCHEMBL994189 0.83 GSTK1 (0.63)
SCHEMBL3515970 0.82 FOLH1 (0.58)
SCHEMBL2868539 0.81 GSTK1 (0.64)
SCHEMBL9253547 0.81 GSTK1 (0.64)
SCHEMBL3012513 0.81 GSTK1 (0.64)
SCHEMBL6361383 0.81 GSTK1 (0.64)
SCHEMBL8462380 0.79 FOLH1 (0.54)
SCHEMBL19179124 0.79 FOLH1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105585579-A Compound, preparation method thereof, and preparation method of maytansine DM1 NANJING LEVENA BIOPHARMA CO LTD 2016-05-18 CN disclosed
US-20100190902-A1 ALKYLTIN SULFANYL ESTER THIOLS CHEMTURA CORPORATION (US) 2010-07-29 US disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed